Literature DB >> 21037560

Inflammation: TREG cell control of autoimmune inflammation: a matter of timing?

Hendrik Schulze-Koops1, Alla Skapenko.   

Abstract

Immunosuppression has been associated with viral reactivation in patients with chronic viral infections. a prospective study has concluded that it is safe to use anti-tumor-necrosis-factor agents in patients with chronic hepatitis B virus infection receiving antiviral prophylaxis. Is there sufficient evidence to back up this conclusion?

Entities:  

Mesh：

Year:  2010        PMID： 21037560     DOI： 10.1038/nrrheum.2010.155

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  9 in total

Review 1.  What does the future hold for cell-based tolerogenic therapy?

Authors:  Jeffrey A Bluestone; Angus W Thomson; Ethan M Shevach; Howard L Weiner
Journal:  Nat Rev Immunol       Date:  2007-08       Impact factor: 53.106

2.  Regulatory T cells protect from local and systemic bone destruction in arthritis.

Authors:  Mario M Zaiss; Benjamin Frey; Andreas Hess; Jochen Zwerina; Julia Luther; Falk Nimmerjahn; Klaus Engelke; George Kollias; Thomas Hünig; Georg Schett; Jean-Pierre David
Journal:  J Immunol       Date:  2010-05-17       Impact factor: 5.422

3.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

4.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

Authors:  B Salomon; D J Lenschow; L Rhee; N Ashourian; B Singh; A Sharpe; J A Bluestone
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

5.  Regulatory T cells control the transition from acute into chronic inflammation in glucose-6-phosphate isomerase-induced arthritis.

Authors:  Oliver Frey; Andreas Reichel; Kerstin Bonhagen; Lars Morawietz; Una Rauchhaus; Thomas Kamradt
Journal:  Ann Rheum Dis       Date:  2010-05-24       Impact factor: 19.103

6.  Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells.

Authors:  Jun Wang; Andreea Ioan-Facsinay; Ellen I H van der Voort; Tom W J Huizinga; René E M Toes
Journal:  Eur J Immunol       Date:  2007-01       Impact factor: 5.532

Review 7.  T-regulatory cells in systemic lupus erythematosus.

Authors:  A La Cava
Journal:  Lupus       Date:  2008-05       Impact factor: 2.911

8.  Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice.

Authors:  David Schubert; Bert Maier; Lars Morawietz; Veit Krenn; Thomas Kamradt
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

9.  Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy.

Authors:  Michael R Ehrenstein; Jamie G Evans; Animesh Singh; Samantha Moore; Gary Warnes; David A Isenberg; Claudia Mauri
Journal:  J Exp Med       Date:  2004-07-26       Impact factor: 14.307
  9 in total
  3 in total

Review 1.  Autoimmune hepatitis.

Authors:  Farhad Sahebjam; John M Vierling
Journal:  Front Med       Date:  2015-03-06       Impact factor: 4.592

Review 2.  Diagnosis and treatment of autoimmune hepatitis.

Authors:  John M Vierling
Journal:  Curr Gastroenterol Rep       Date:  2012-02

3.  Regulatory T cells with a defect in inhibition on co-stimulation deteriorated primary biliary cholangitis.

Authors:  Jianing Chen; Xianliang Hou; Hongyu Jia; Guangying Cui; Zhongwen Wu; Lin Wang; Chong Lu; Wei Wu; Yingfeng Wei; Toshimitsu Uede; Lanjuan Li; Zhexiong Lian; Hongyan Diao
Journal:  Oncotarget       Date:  2017-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.